KR840006222A - 피페리딘 유도체의 제조방법 - Google Patents
피페리딘 유도체의 제조방법 Download PDFInfo
- Publication number
- KR840006222A KR840006222A KR1019830004475A KR830004475A KR840006222A KR 840006222 A KR840006222 A KR 840006222A KR 1019830004475 A KR1019830004475 A KR 1019830004475A KR 830004475 A KR830004475 A KR 830004475A KR 840006222 A KR840006222 A KR 840006222A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- represent
- compound
- different
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 하기 일반식(Ⅱ)의 4-아미노퀴녹살린을 하기 일반식(Ⅲ)의 피페리딘 유도체와 반응시키거나, 하기 일반식(Ⅳ)의 화합물을 하기 일반식(Ⅴ)의 디알킬 카보네이트와 반응시키거나, 하기 일반식(Ⅵ)의 화합물을 하기 일반식(Ⅶ)의 히드록시카복실산 에스테르와 반응시키거나, 하기 일반식(Ⅷ)의 화합물을 염화암모늄 및 포름아미드와 반응시키고, 수득된 화합물을 염기 또는 산부가염형태로 분리시킴을 특징으로 하여, 유리염기 및 산부가염형태, 임의로 라세미체 또는 광학이성체 혼합물 또는 순수한 에난티오머형태의 하기 일반식(Ⅰ)화합물을 제조하는 방법.상기 일반식에서 R1과 R2는 서로 동일하거나 다를 수도 있으며, 수소, C1-8알킬 또는 아릴메틸을 나타내거나 R1과 R2는 함께 -(CH2)4- 또는 -(CH2)5-를 나타낼 수 있고, R3와 R4는 서로 동일하거나 다를수도 있으며, 수소, C1-4알킬 또는 아릴메틸을 나타내거나 R3와 R4는 함께 -CH2- 또는 -CH2-CH2-을 나타낼 수 있으며, R과 R'는 서로 동일하거나 다를 수도 있으며, 임의로 분자된 C1-6알킬그룹을 나타내며, X는 염소, 브롬 또는 C1-4알킬티오를 나타낸다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823235565 DE3235565A1 (de) | 1982-09-25 | 1982-09-25 | Piperidinderivate, ihre herstellung und verwendung |
| DEP3235565.3? | 1982-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR840006222A true KR840006222A (ko) | 1984-11-22 |
Family
ID=6174159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019830004475A KR840006222A (ko) | 1982-09-25 | 1983-09-24 | 피페리딘 유도체의 제조방법 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4539323A (ko) |
| EP (1) | EP0104445A3 (ko) |
| JP (1) | JPS5978187A (ko) |
| KR (1) | KR840006222A (ko) |
| AU (1) | AU561118B2 (ko) |
| CA (1) | CA1215981A (ko) |
| CS (1) | CS235342B2 (ko) |
| DD (1) | DD212517A5 (ko) |
| DE (1) | DE3235565A1 (ko) |
| DK (1) | DK436583A (ko) |
| ES (4) | ES8501762A1 (ko) |
| FI (1) | FI833292A (ko) |
| GR (1) | GR78973B (ko) |
| HU (1) | HU191637B (ko) |
| IL (1) | IL69777A (ko) |
| NO (1) | NO833423L (ko) |
| NZ (1) | NZ205716A (ko) |
| PH (1) | PH20015A (ko) |
| PL (1) | PL139590B1 (ko) |
| PT (1) | PT77380B (ko) |
| SU (1) | SU1187720A3 (ko) |
| YU (1) | YU192183A (ko) |
| ZA (1) | ZA837081B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4601897A (en) * | 1985-11-06 | 1986-07-22 | Pfizer Inc. | Prazosin-pirbuterol combination for bronchodilation |
| JPS62212385A (ja) * | 1986-03-13 | 1987-09-18 | Kotobuki Seiyaku Kk | キナゾリン誘導体並びに血圧降下剤及びその製法 |
| US7799794B2 (en) * | 2000-06-28 | 2010-09-21 | Merck Sharp & Dohme Corp. | Treatment for cardiovascular disease |
| EP1522039B1 (en) | 2002-07-01 | 2008-06-04 | Tibotec Pharmaceuticals Ltd. | New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| FR2854633B1 (fr) * | 2003-05-07 | 2005-06-24 | Sanofi Synthelabo | Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique |
| FR2866885B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309541A (en) * | 1978-09-20 | 1982-01-05 | Ciba-Geigy Corporation | Piperidinyl-lactams |
| EP0009465A1 (de) * | 1978-09-20 | 1980-04-02 | Ciba-Geigy Ag | N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen |
| FR2483920A1 (fr) * | 1980-06-09 | 1981-12-11 | Synthelabo | Nouveaux derives de quinazoline, leur procede de preparation et leur application en therapeutique |
-
1982
- 1982-09-25 DE DE19823235565 patent/DE3235565A1/de not_active Withdrawn
-
1983
- 1983-08-25 EP EP83108375A patent/EP0104445A3/de not_active Withdrawn
- 1983-09-13 SU SU833641410A patent/SU1187720A3/ru active
- 1983-09-14 US US06/531,842 patent/US4539323A/en not_active Expired - Fee Related
- 1983-09-15 FI FI833292A patent/FI833292A/fi not_active Application Discontinuation
- 1983-09-20 JP JP58174020A patent/JPS5978187A/ja active Pending
- 1983-09-20 PH PH29564A patent/PH20015A/en unknown
- 1983-09-21 IL IL69777A patent/IL69777A/xx unknown
- 1983-09-22 CS CS836919A patent/CS235342B2/cs unknown
- 1983-09-22 GR GR72505A patent/GR78973B/el unknown
- 1983-09-23 YU YU01921/83A patent/YU192183A/xx unknown
- 1983-09-23 DD DD83255091A patent/DD212517A5/de unknown
- 1983-09-23 ZA ZA837081A patent/ZA837081B/xx unknown
- 1983-09-23 PT PT77380A patent/PT77380B/pt unknown
- 1983-09-23 CA CA000437468A patent/CA1215981A/en not_active Expired
- 1983-09-23 PL PL1983243878A patent/PL139590B1/pl unknown
- 1983-09-23 DK DK436583A patent/DK436583A/da not_active Application Discontinuation
- 1983-09-23 AU AU19396/83A patent/AU561118B2/en not_active Withdrawn - After Issue
- 1983-09-23 NZ NZ205716A patent/NZ205716A/xx unknown
- 1983-09-23 NO NO833423A patent/NO833423L/no unknown
- 1983-09-23 ES ES525876A patent/ES8501762A1/es not_active Expired
- 1983-09-23 HU HU833307A patent/HU191637B/hu unknown
- 1983-09-24 KR KR1019830004475A patent/KR840006222A/ko not_active Application Discontinuation
-
1984
- 1984-07-16 ES ES534349A patent/ES8504180A1/es not_active Expired
- 1984-07-16 ES ES534351A patent/ES534351A0/es active Granted
- 1984-07-16 ES ES534350A patent/ES534350A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| PL139590B1 (en) | 1987-02-28 |
| HU191637B (en) | 1987-03-30 |
| ES8504181A1 (es) | 1985-04-01 |
| ES525876A0 (es) | 1984-12-01 |
| US4539323A (en) | 1985-09-03 |
| SU1187720A3 (ru) | 1985-10-23 |
| ES534350A0 (es) | 1985-04-01 |
| DE3235565A1 (de) | 1984-03-29 |
| IL69777A (en) | 1986-09-30 |
| ES8501762A1 (es) | 1984-12-01 |
| PT77380A (de) | 1983-10-01 |
| PH20015A (en) | 1986-08-28 |
| ES8504182A1 (es) | 1985-04-01 |
| DD212517A5 (de) | 1984-08-15 |
| NZ205716A (en) | 1985-08-30 |
| ES534349A0 (es) | 1985-04-01 |
| PL243878A1 (en) | 1985-01-02 |
| FI833292A (fi) | 1984-03-26 |
| PT77380B (de) | 1986-03-20 |
| EP0104445A3 (de) | 1985-07-10 |
| ES8504180A1 (es) | 1985-04-01 |
| ES534351A0 (es) | 1985-04-01 |
| YU192183A (ko) | 1986-12-31 |
| AU561118B2 (en) | 1987-04-30 |
| CS235342B2 (en) | 1985-05-15 |
| JPS5978187A (ja) | 1984-05-04 |
| DK436583D0 (da) | 1983-09-23 |
| DK436583A (da) | 1984-03-26 |
| NO833423L (no) | 1984-03-26 |
| EP0104445A2 (de) | 1984-04-04 |
| ZA837081B (en) | 1985-05-29 |
| CA1215981A (en) | 1986-12-30 |
| GR78973B (ko) | 1984-10-02 |
| AU1939683A (en) | 1984-03-29 |
| FI833292A0 (fi) | 1983-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840004406A (ko) | 히단토인의 제조방법 | |
| BR9002311A (pt) | Composto e processo para sua preparacao,composicao fungicida e processo para controlar fungos fitopatogenicos | |
| KR840001175A (ko) | [3H]-이미다조 [5,1-d]-1,2,3,5- 테트라진-4-온 유도체의 제조방법 | |
| KR850004492A (ko) | 옥시캄의 엔올 에테르 유도체의 제조방법 | |
| KR840001148A (ko) | 헤테로사이클릭 치환기를 가지는 설포닐우레아의 제조방법 | |
| KR840006222A (ko) | 피페리딘 유도체의 제조방법 | |
| KR830005090A (ko) | 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔 산(酸) | |
| KR850007601A (ko) | 페남 유도체의 제조방법 | |
| KR850001907A (ko) | 구충제 화화물 및 조성물의 제조방법 | |
| KR850002460A (ko) | 카르바메이트 화합물의 제조방법 | |
| KR870003107A (ko) | 키산틴 유도체의 제조방법 | |
| KR850005847A (ko) | 피리미도[2,1-b] 벤조티아졸 및 그것의 염들의 제조방법 | |
| KR890006620A (ko) | 퀴놀린 유도체 및 그의 제조법 | |
| KR840006481A (ko) | 테트라졸화합물의 제조방법 및 이들화합물을 유효성분으로 하는 항균 및 항미 조성물 | |
| SE8801518D0 (sv) | A novel process | |
| KR850004959A (ko) | 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법 | |
| KR830006160A (ko) | 1-아릴-사이클로프로판-1-카복실산 에스테르의 제조방법 | |
| KR840003627A (ko) | 4-피페라지닐-4-페닐 퀴나졸린 유도체의 제조방법 | |
| ATE123286T1 (de) | Verfahren zur herstellung von 3-alkoxymethyl cephalosporinderivate. | |
| KR850004587A (ko) | 치환된 n-페닐-n'-아실이소티오우레아의 제조방법 | |
| KR850005448A (ko) | 펜옥시 프로피오닐옥시 알칸 포스포네이트의 제조방법 | |
| KR840004735A (ko) | 시클로프로판 카르복실산 유도체의 제조방법 및 조성물 | |
| KR860004051A (ko) | 치환된 페닐피페라진 유도체의 제조방법 | |
| KR860002474A (ko) | 치환된 페닐술포닐아졸의 제조방법 | |
| KR890005136A (ko) | 아제티디논 n-포스포노메틸 에스테르 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |